Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Trial of basic Fibroblast Growth Factor Plus Narrowband UVB in Vitiligo
IRCT20201104049265N1Phase 4Completed
- Sponsor
- Imen Vaccine Alborz
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitiligo comparing bFGF + NBUVB with Placebo + NBUVB (2 arms). Started Jul 2021; status: completed.
02
Drugs
trafermin
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20201104049265N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201104049265N1.